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Introduction
Antiphospholipid syndrome (APS), either primary or
secondary to other paediatric rheumatic diseases, is rare in
children, but it can lead to significant morbidity. Evidence-
based guidelines are sparse and management is mostly
based on physician’s experience. Consequently, treatment
regimens differ throughout Europe. In 2012, a European
initiative called SHARE (Single Hub and Access point for
paediatric Rheumatology in Europe) was launched to
optimize and disseminate diagnostic and management
regimens in Europe for children and young adults with
rheumatic diseases such as APS.
Objectives
To provide evidence based recommendations for
diagnosis and treatment of APS.
Methods
Evidence based recommendations were developed using
the European League Against Rheumatism (EULAR)
standard operating procedure. An expert committee was
instituted, consisting of paediatric rheumatologists from
across Europe with expertise in APS. The expert commit-
tee defined search terms for the systematic literature
review, which was performed in summer 2013. Two
independent experts scored articles for validity and level of
evidence. Recommendations derived from the literature
were evaluated by an online survey. Those with less
than 80% agreement during the online survey were
reformulated. Subsequently, all recommendations were
discussed at a consensus meeting using the nominal group
technique[1]. Recommendations were accepted if more
than 80% agreement was reached.
Results
The literature search yielded 1463 articles, of which 15
(all relating to diagnosis only, none were relevant for treat-
ment) were considered relevant and therefore scored for
validity and level of evidence. Only 8 articles were deemed
valid and were used in the formulation of the recommen-
dations. In view of paucity of paediatric-specific data, the
majority of proposed recommendations were developed
based on adult-derived literature or expert opinion. Four
recommendations for diagnosis and 2 for treatment were
suggested in the online survey. During the consensus
meeting, recommendations based on expert opinion were
added. Three recommendations for diagnosis and 6 for
treatment were accepted with more than 80% agreement
after the consensus meeting. Table 1 summarizes the
categories of recommendations.
Conclusion
The SHARE initiative provides recommendations for
diagnosis and treatment for APS and thereby facilitates
improvement and uniformity of care throughout Europe.
Currently, a similar process is going on to add additional
guidelines including those on holistic care for PRD
patients. As a final result, SHARE will provide standards
of minimal care for different PRDs, including APS.
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